Prot# A8811020: A Phase 2 Randomized, Double-Blind, Double-Dummy Efficacy, Safety and Tolerability Study of IV Sulopenem with Switch to Oral PF-03709270 Compared to Ceftriaxone with Step Down to Amoxicillin/Clavulanate Potassium (Augmentin) in Subjects wi

Project: Research project

Project Details

StatusFinished
Effective start/end date1/28/09 → 1/28/12

Funding

  • ICON Clinical Research, LLC (A8811020 // A8811020)
  • Pfizer Inc. (A8811020 // A8811020)